Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Athira Pharma Inc (NASDAQ: ATHA) closed at $0.52 in the last session, down -5.86% from day before closing price of $0.56. In other words, the price has decreased by -$5.86 from its previous closing price. On the day, 0.6 million shares were traded. ATHA stock price reached its highest trading level at $0.5475 during the session, while it also had its lowest trading level at $0.5006.
Ratios:
We take a closer look at ATHA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.95 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Mizuho on September 19, 2024, Downgraded its rating to Neutral and sets its target price to $0.50 from $5 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 02 ’25 when San Martin Javier sold 10,826 shares for $0.56 per share. The transaction valued at 6,083 led to the insider holds 35,841 shares of the business.
Litton Mark James sold 25,107 shares of ATHA for $14,108 on Jan 02 ’25. The President and CEO now owns 242,591 shares after completing the transaction at $0.56 per share. On Jan 02 ’25, another insider, CHURCH KEVIN, who serves as the CHIEF SCIENTIFIC OFFICER of the company, sold 8,510 shares for $0.56 each. As a result, the insider received 4,782 and left with 130,761 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATHA now has a Market Capitalization of 20204604 and an Enterprise Value of -61532468.
Stock Price History:
The Beta on a monthly basis for ATHA is 2.97, which has changed by -0.8203883 over the last 52 weeks, in comparison to a change of 0.23883796 over the same period for the S&P500. Over the past 52 weeks, ATHA has reached a high of $4.30, while it has fallen to a 52-week low of $0.41. The 50-Day Moving Average of the stock is -12.40%, while the 200-Day Moving Average is calculated to be -67.97%.
Shares Statistics:
According to the various share statistics, ATHA traded on average about 4.82M shares per day over the past 3-months and 164340 shares per day over the past 10 days. A total of 38.67M shares are outstanding, with a floating share count of 35.36M. Insiders hold about 8.55% of the company’s shares, while institutions hold 47.81% stake in the company. Shares short for ATHA as of 1728950400 were 1557749 with a Short Ratio of 0.24, compared to 1726185600 on 1645197. Therefore, it implies a Short% of Shares Outstanding of 1557749 and a Short% of Float of 5.7600003.
